Library / Laws / 115th Congress / House Bills / H.R. 2212
H.R. 2212
To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2017-04-27 | 18.7K | ⠃⠗⠋ |